{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:55:25Z","timestamp":1767927325760,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.saa.2020.118533","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T22:16:07Z","timestamp":1590617767000},"page":"118533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["An enhanced first derivative synchronous spectrofluorimetric method for determination of the newly co-formulated drugs, amlodipine and celecoxib in pharmaceutical preparation and human plasma"],"prefix":"10.1016","volume":"240","author":[{"given":"Khaled","family":"Attala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya S.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda M.","family":"El-Henawee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soad S.","family":"Abd El-Hay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2020.118533_bb0005","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/17512433.2018.1540299","article-title":"Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain","volume":"11","author":"Angeli","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.saa.2020.118533_bb0010","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/rheumatology\/kem191","article-title":"Vascular pathology and osteoarthritis","volume":"46","author":"Findlay","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.saa.2020.118533_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjmed.2018.08.027","article-title":"Fixed-dose combination amlodipine\/celecoxib (Consensi) for hypertension and osteoarthritis","volume":"132","author":"Smith","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.saa.2020.118533_bb0020","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.saa.2020.118533_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.rehab.2016.01.006","article-title":"Risk factors and burden of osteoarthritis","volume":"59","author":"Palazzo","year":"2016","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"10.1016\/j.saa.2020.118533_bb0030","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1517\/14656566.8.11.1719","article-title":"Clinical pharmacology of celecoxib, a COX-2 selective inhibitor","volume":"8","author":"Antoniou","year":"2007","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.saa.2020.118533_bb0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.farmac.2005.02.003","article-title":"Study on the inclusion complex between \u03b2-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application","volume":"60","author":"Manzoori","year":"2005","journal-title":"Farmaco"},{"key":"10.1016\/j.saa.2020.118533_bb0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/jssc.200500412","article-title":"Simultaneous determination of celecoxib, meloxicam, and rofecoxib using capillary electrophoresis with surfactant and application in drug formulations","volume":"29","author":"Hsieh","year":"2006","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.saa.2020.118533_bb0045","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1039\/D0AY00237B","article-title":"Improving the determination of celecoxib in body fluids and pharmaceuticals using a new selective and thermosensitive molecularly imprinted poly(vinylidene fluoride) membrane","author":"Yazdanian","year":"2020","journal-title":"Anal. Methods"},{"key":"10.1016\/j.saa.2020.118533_bb0050","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0731-7085(01)00523-4","article-title":"Stability-indicating methods for the determination of doxazosin mezylate and celecoxib","volume":"27","author":"Bebawy","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2020.118533_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1134\/S1061934815020203","article-title":"A sensitive chemiluminescence method for the determination of celecoxib in pharmaceutical and biological samples","volume":"70","author":"Hallaj","year":"2015","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.saa.2020.118533_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000175050","article-title":"Pharmacokinetics and pharmacodynamics of amlodipine","volume":"80","author":"Abernethy","year":"1992","journal-title":"Cardiology"},{"key":"10.1016\/j.saa.2020.118533_bb0065","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jpba.2005.04.001","article-title":"Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product","volume":"39","author":"Naidu","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2020.118533_bb0070","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0250-474X.103849","article-title":"Development and validation of HPTLC method for simultaneous determination of amlodipine besylate and metoprolol succinate in bulk and tablets","volume":"74","author":"Jain","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2020.118533_bb0075","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.snb.2014.08.078","article-title":"An improved method for simultaneous square-wave voltammetric determination of amlodipine and enalapril at multi-walled carbon nanotubes paste electrode based on effect of cationic surfactant","volume":"205","author":"Valezi","year":"2014","journal-title":"Sensors Actuators B Chem."},{"key":"10.1016\/j.saa.2020.118533_bb0080","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1590\/S1984-82502012000400016","article-title":"Spectrofluorimetric determination of amlodipine in human plasma without derivatization","volume":"48","author":"Kadioglu","year":"2012","journal-title":"Brazilian J. Pharm. Sci."},{"key":"10.1016\/j.saa.2020.118533_bb0085","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/bio.3575","article-title":"Development of a micelle-enhanced high-throughput fluorometric method for determination of niclosamide using a microplate reader","volume":"34","author":"Abd El-Hay","year":"2019","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2020.118533_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0022-2313(78)90083-2","article-title":"Influence of surfactants on the fluorescence and absorption spectra of erythrosin in aqueous solution","volume":"17","author":"Kapoor","year":"1978","journal-title":"J. Lumin."},{"key":"10.1016\/j.saa.2020.118533_bb0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0026-265X(85)90007-4","article-title":"Effect of surfactants on the fluorescence intensity of organic reagents","volume":"31","author":"Grases","year":"1985","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2020.118533_bb0100","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1039\/b9ay00208a","article-title":"Sensitive surfactant-mediated spectrofluorimetric determination of sildenafil","volume":"2","author":"Wang","year":"2010","journal-title":"Anal. Methods"},{"key":"10.1016\/j.saa.2020.118533_bb0105","series-title":"UV Spectroscopic Method for Simultaneous Estimation of Celecoxib and Amlodipine","first-page":"48","volume":"2","author":"Pathak","year":"2017"},{"key":"10.1016\/j.saa.2020.118533_bb0110","doi-asserted-by":"crossref","first-page":"104365","DOI":"10.1016\/j.microc.2019.104365","article-title":"Validation of rapid RP-HPLC method for concurrent quantification of amlodipine and celecoxib in pure and formulation using an experimental design","volume":"152","author":"Attimarad","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2020.118533_bb0115","first-page":"1","article-title":"Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation","volume":"14","author":"Attimarad","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.saa.2020.118533_bb0120","first-page":"1","article-title":"Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline","volume":"5","author":"El Abass","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.saa.2020.118533_bb0125","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0021-9797(74)90030-7","article-title":"The critical micelle concentration of sodium dodecyl sulfate-bivalent metal dodecyl sulfate mixtures in aqueous solutions","volume":"46","author":"Moroi","year":"1974","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.saa.2020.118533_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/9781118971147.ch5","article-title":"Q2(R1) validation of analytical procedures","volume":"2","author":"Borman","year":"2017","journal-title":"ICH Qual. Guidel."},{"key":"10.1016\/j.saa.2020.118533_bb0135","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/009127000004001206","article-title":"Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers","volume":"40","author":"Stangier","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.saa.2020.118533_bb0140","doi-asserted-by":"crossref","unstructured":"N.M. Davies, A.J. McLachlan, R.O. Day, K.M. Williams, Clinical pharmacokinetics and pharmacodynamics of celecoxib. A selective cyclo-oxygenase-2 inhibitor, Clin. Pharmacokinet. 38 (2000) 225\u2013242. doi:https:\/\/doi.org\/10.2165\/00003088-200038030-00003.","DOI":"10.2165\/00003088-200038030-00003"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142520305126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142520305126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:33:39Z","timestamp":1761356019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142520305126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"alternative-id":["S1386142520305126"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2020.118533","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An enhanced first derivative synchronous spectrofluorimetric method for determination of the newly co-formulated drugs, amlodipine and celecoxib in pharmaceutical preparation and human plasma","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2020.118533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118533"}}